Portfolio company
Icosavax
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
Digital Health
About
The company develops virus-like particle vaccines for respiratory infectious diseases, such as respiratory syncytial virus and human metapneumovirus, primarily for older adult patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.